T. Rowe Price Investment Management, Inc. Arvinas, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,208,234 shares of ARVN stock, worth $39.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,208,234Holding current value
$39.2 Million% of portfolio
0.03%Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.9MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$126 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$120 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$111 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$72.9 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$59.3 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $945M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...